These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32745472)

  • 1. Loss of diffuse noxious inhibitory control after traumatic brain injury in rats: A chronic issue.
    Irvine KA; Sahbaie P; Ferguson AR; Clark JD
    Exp Neurol; 2020 Nov; 333():113428. PubMed ID: 32745472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine control of descending pain modulation after mild traumatic brain injury.
    Sahbaie P; Irvine KA; Shi XY; Clark JD
    Sci Rep; 2022 Sep; 12(1):16359. PubMed ID: 36175479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the noradrenergic and serotonergic contributions of diffuse noxious inhibitory controls in a monoiodoacetate model of osteoarthritis.
    Lockwood SM; Bannister K; Dickenson AH
    J Neurophysiol; 2019 Jan; 121(1):96-104. PubMed ID: 30461363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the Locus Coeruleus Mediated by Designer Receptor Exclusively Activated by Designer Drug Restores Descending Nociceptive Inhibition after Traumatic Brain Injury in Rats.
    Irvine KA; Peters CM; Vazey EM; Ferguson AR; Clark JD
    J Neurotrauma; 2022 Jul; 39(13-14):964-978. PubMed ID: 35412843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse noxious inhibitory controls and nerve injury: restoring an imbalance between descending monoamine inhibitions and facilitations.
    Bannister K; Patel R; Goncalves L; Townson L; Dickenson AH
    Pain; 2015 Sep; 156(9):1803-1811. PubMed ID: 26010460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duloxetine ameliorates the impairment of diffuse noxious inhibitory control in rat models of peripheral neuropathic pain and knee osteoarthritis pain.
    Yoneda S; Kasai E; Matsuo M; Tamano R; Sakurai Y; Asaki T; Fujita M
    Neurosci Lett; 2020 Jun; 729():134990. PubMed ID: 32315711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache.
    Kopruszinski CM; Turnes JM; Swiokla J; Weinstein TJ; Schwedt TJ; Dodick DW; Anderson T; Navratilova E; Porreca F
    Cephalalgia; 2021 May; 41(6):749-759. PubMed ID: 33615840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation into the inhibitory function of serotonin in diffuse noxious inhibitory controls in the neuropathic rat.
    Bannister K; Lockwood S; Goncalves L; Patel R; Dickenson AH
    Eur J Pain; 2017 Apr; 21(4):750-760. PubMed ID: 27891703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traumatic Brain Injury Disrupts Pain Signaling in the Brainstem and Spinal Cord.
    Irvine KA; Sahbaie P; Liang DY; Clark JD
    J Neurotrauma; 2018 Jul; 35(13):1495-1509. PubMed ID: 29373948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa opioid signaling in the right central amygdala causes hind paw specific loss of diffuse noxious inhibitory controls in experimental neuropathic pain.
    Phelps CE; Navratilova E; Dickenson AH; Porreca F; Bannister K
    Pain; 2019 Jul; 160(7):1614-1621. PubMed ID: 30870321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired diffuse noxious inhibitory controls in specific alternation of rhythm in temperature-stressed rats.
    Itomi Y; Tsukimi Y; Kawamura T
    Eur J Pharmacol; 2016 Aug; 784():61-8. PubMed ID: 27178898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of the Diffuse Noxious Inhibitory Controls in Chronic Joint Inflammatory Pain Is Accompanied by Anxiodepressive-Like Behaviors and Impairment of the Descending Noradrenergic Modulation.
    Pereira-Silva R; Costa-Pereira JT; Alonso R; Serrão P; Martins I; Neto FL
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents.
    Jones CK; Peters SC; Shannon HE
    J Pharmacol Exp Ther; 2005 Feb; 312(2):726-32. PubMed ID: 15494550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antinociceptive effect of milnacipran in the monosodium iodoacetate model of osteoarthritis pain and its relation to changes in descending inhibition.
    Burnham LJ; Dickenson AH
    J Pharmacol Exp Ther; 2013 Mar; 344(3):696-707. PubMed ID: 23297162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced descending pain facilitation in acute traumatic brain injury.
    Irvine KA; Sahbaie P; Ferguson AR; Clark JD
    Exp Neurol; 2019 Oct; 320():112976. PubMed ID: 31185197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated Administration of Duloxetine Suppresses Neuropathic Pain by Accumulating Effects of Noradrenaline in the Spinal Cord.
    Ito S; Suto T; Saito S; Obata H
    Anesth Analg; 2018 Jan; 126(1):298-307. PubMed ID: 28787337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse noxious inhibitory controls in chronic joint inflammatory Pain: Study of the descending serotonergic modulation mediated through 5HT3 receptors.
    Pereira-Silva R; Serrão P; Lourença Neto F; Martins I
    Neurobiol Pain; 2023; 13():100123. PubMed ID: 36915290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supraspinal Projection of Serotonergic and Noradrenergic Pathways Modulates Nociceptive Transmission in the Lower Urinary Tract of Rats.
    Mitsui T; Kanno Y; Kitta T; Moriya K; Nonomura K
    Low Urin Tract Symptoms; 2016 Sep; 8(3):186-90. PubMed ID: 27619785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin reuptake inhibitors do not prevent 5,7-dihydroxytryptamine-induced depletion of serotonin in rat brain.
    Choi S; Jonak E; Fernstrom JD
    Brain Res; 2004 May; 1007(1-2):19-28. PubMed ID: 15064132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
    Jones CK; Eastwood BJ; Need AB; Shannon HE
    Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.